SG Americas Securities
RVPH

SG Americas Securities’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

SG Americas Securities’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-578
Closed -$4K – 3738
2025
Q3 		$4K Buy
+578
New +$4.91K ﹤0.01% 3339

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities's RVPH Position: Q4 2025 in Review

SG Americas Securities sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2025, closing a stake of 578 shares — an estimated $4K sold.

SG Americas Securities first reported a position in RVPH in Q3 2025 and held it in 1 quarter. The position peaked at $4K in Q3 2025. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

  • SG Americas Securities reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2025 after selling out during the quarter.
  • SG Americas Securities sold 578 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $4K.
  • SG Americas Securities first reported a position in REVIVA PHARMA HLDGS INC in Q3 2025 and held it in 1 quarter.
  • SG Americas Securities's REVIVA PHARMA HLDGS INC position peaked at $4K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on SG Americas Securities's 13F filing for Q4 2025, filed 9 Jan 2026.